Evaluation of a clinical scoring scale to direct early appropriate therapy in heparin-induced thrombocytopenia

Journal of Oncology Pharmacy Practice

Volumn 16, Issue 3, 2010, Pages 161-166

  Wirth, Scott M ^a   MacAulay, Tracy E ^a,b   Armitstead, John A ^a   Steinke, Douglas T ^b   Blechner, Michael D ^a   Lewis, Daniel A ^a,b,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c Gill Heart Institute ^*  (United States)

Author keywords

hematology; immunology; thrombocytopenia

Indexed keywords

ARGATROBAN; DROTRECOGIN;

4T SCORING SYSTEM; ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; THROMBOCYTE COUNT; THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION TESTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 77956234403     PISSN: 10781552     EISSN: None     Source Type: Journal    
DOI: 10.1177/1078155209342133     Document Type: Article

References (21)

1. Arepally GM, Ortel TL Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med 2006 ; 355: 809-817.
2. Napolitano LM, Warkentin TE, Almahameed A., Nasraway SA Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management. Crit Care Med 2006 ; 34: 2898-2911.
3. Warkentin TE, Greinacher A., Koster A., Lincoff AM American College of Chest Physicians. Treatment and prevention of heparin-induced thrombocytopenia: American College of chest physicians evidence-based clinical practice guidelines. Chest. Vol. 133, 8 th edition, 2008: 340S - 80S.
4. Warkentin TE, Hayward CP, Boshkov LK, Santos AV, Sheppard JA, Bode AP et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994 ; 84: 3691-3699.
5. Newman PM, Chong BH Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation. Blood 2000 ; 96: 182-187.
6. Walenga JM, Jeske WP, Messmore HL Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia. J Thromb Thrombolysis 2000 ; 10 (Suppl 1). 13-20.
7. Warkentin TE, Kelton JG A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996 ; 101: 502-507.
8. Greinacher A., Warkentin TE Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update. Thromb Res 2006 ; 118: 165-176.
9. Wallis DE, Workman DL, Lewis BE, Steen L., Pifarre R., Moran JF Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. Am J Med 1999 ; 106: 629-635.
10. Warkentin TE Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 2003 ; 121: 535-555.
11. Weiss BM, Shumway NM, Howard RS, Ketchum LK, Reid TJ Optical density values correlate with the clinical probability of heparin induced thrombocytopenia. J Thromb Thrombolysis 2007 ; 26: 243-247.
12. Warkentin TE, Heddle NM Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep 2003 ; 2: 148-157.
13. Greinacher A., Janssens U., Berg G., Böck M., Kwasny H., Kemkes-Matthes B. et al. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-associated Thrombocytopenia Study (HAT) investigators. Circulation 1999 ; 100: 587-593.
14. Greinacher A., Völpel H., Janssens U., Hach-Wunderle V., Kemkes-Matthes B., Eichler P. et al. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study. Circulation 1999 ; 99: 73-80.
15. Lubenow N., Eichler P., Lietz T., Greinacher A., Hit Investigators. Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3. J Thromb Haemost 2005 ; 3: 2428-2436.
16. Lo GK, Juhl D., Warkentin TE, Sigouin CS, Eichler P., Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 2006 ; 4: 759-765.
17. Lewis BE, Wallis DE, Leya F., Hursting MJ, Kelton JG Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. Arch Intern Med 2003 ; 163: 1849-1856.
18. Lewis BE, Wallis DE, Hursting MJ, Levine RL, Leya F. Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia. Chest 2006 ; 129: 1407-1416.
19. Lewis BE, Wallis DE, Berkowitz SD, Matthai WH, Fareed J., Walenga JM et al. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 2001 ; 103: 1838-1843.
20. Dager WE, White RH Treatment of heparin-induced thrombocytopenia. Ann Pharmacother 2002 ; 36: 489-503.
21. Davoren A., Aster RH Heparin-induced thrombocytopenia and thrombosis. Am J Hematol 2006 ; 81: 36-44.